Zacks: Analysts Expect Cross Country Healthcare, Inc. (NASDAQ:CCRN) Will Announce Quarterly Sales of $199.50 Million

Equities analysts forecast that Cross Country Healthcare, Inc. (NASDAQ:CCRN) will announce $199.50 million in sales for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Cross Country Healthcare’s earnings, with the lowest sales estimate coming in at $197.38 million and the highest estimate coming in at $200.40 million. Cross Country Healthcare reported sales of $204.57 million during the same quarter last year, which indicates a negative year over year growth rate of 2.5%. The business is expected to announce its next earnings report after the market closes on Wednesday, July 31st.

On average, analysts expect that Cross Country Healthcare will report full year sales of $802.93 million for the current financial year, with estimates ranging from $795.33 million to $808.44 million. For the next financial year, analysts anticipate that the business will report sales of $835.17 million, with estimates ranging from $809.33 million to $854.03 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Cross Country Healthcare.

Cross Country Healthcare (NASDAQ:CCRN) last posted its earnings results on Wednesday, May 1st. The business services provider reported $0.02 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.04) by $0.06. The firm had revenue of $195.10 million for the quarter, compared to the consensus estimate of $198.47 million. Cross Country Healthcare had a negative net margin of 2.54% and a positive return on equity of 1.19%. The business’s quarterly revenue was down 7.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.06 earnings per share.

Several equities research analysts recently commented on the stock. Zacks Investment Research raised shares of HB Fuller from a “sell” rating to a “hold” rating in a research report on Wednesday, July 3rd. Barrington Research set a $10.00 price target on shares of Atento and gave the stock a “buy” rating in a research report on Monday, May 20th. ValuEngine raised shares of Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Monday, April 1st. Finally, BidaskClub raised shares of Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Thursday, June 20th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Cross Country Healthcare has an average rating of “Hold” and a consensus price target of $9.83.

In other Cross Country Healthcare news, CEO Kevin Cronin Clark purchased 8,330 shares of the business’s stock in a transaction on Friday, June 14th. The shares were purchased at an average cost of $8.00 per share, with a total value of $66,640.00. Following the transaction, the chief executive officer now directly owns 250,734 shares of the company’s stock, valued at approximately $2,005,872. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 3.80% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Principal Financial Group Inc. raised its holdings in Cross Country Healthcare by 0.4% during the 4th quarter. Principal Financial Group Inc. now owns 294,310 shares of the business services provider’s stock valued at $2,157,000 after buying an additional 1,252 shares during the last quarter. Legal & General Group Plc increased its position in Cross Country Healthcare by 1.8% during the fourth quarter. Legal & General Group Plc now owns 78,351 shares of the business services provider’s stock worth $577,000 after buying an additional 1,397 shares during the period. Crossmark Global Holdings Inc. increased its position in Cross Country Healthcare by 4.6% during the second quarter. Crossmark Global Holdings Inc. now owns 32,340 shares of the business services provider’s stock worth $303,000 after buying an additional 1,430 shares during the period. Rhumbline Advisers increased its position in Cross Country Healthcare by 1.6% during the first quarter. Rhumbline Advisers now owns 107,645 shares of the business services provider’s stock worth $757,000 after buying an additional 1,685 shares during the period. Finally, Clearbridge Investments LLC increased its position in Cross Country Healthcare by 0.9% during the first quarter. Clearbridge Investments LLC now owns 309,993 shares of the business services provider’s stock worth $2,179,000 after buying an additional 2,906 shares during the period. Institutional investors and hedge funds own 93.67% of the company’s stock.

Shares of CCRN stock traded up $0.10 on Monday, hitting $9.07. The stock had a trading volume of 659 shares, compared to its average volume of 183,859. The firm has a market cap of $328.89 million, a price-to-earnings ratio of 75.67, a P/E/G ratio of 17.59 and a beta of 1.24. Cross Country Healthcare has a twelve month low of $6.75 and a twelve month high of $12.12. The company has a fifty day simple moving average of $8.39. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.08 and a current ratio of 2.08.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.

Featured Story: How is a price target determined?

Get a free copy of the Zacks research report on Cross Country Healthcare (CCRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.